Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response

Clinical trial NCT00285376 · COMPLETED

Trial details

NCT number: NCT00285376
Sponsor: Genaissance Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2006-02-01
Primary completion: 2007-05-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.